May 17 (Reuters) - Moderna (MRNA.O), opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine ...

Moderna said Friday that the European Patent ... rival COVID-19 vaccines. Cambridge-based Moderna has been fighting Pfizer and BioNTech in the courts over the partners’ COVID shot, called ...

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

Who knows, perhaps Genevant, with its billionaire hedge fund owner, or even little Arbutus, might have had a shot at COVID ... to dismiss Moderna's case, insisting that Moderna's patents are ...

When a novel respiratory virus emerged and sparked global worries, Moderna responded with a new infectious disease division. The biotech’s scientists developed a messenger RNA vaccine that ...

Moderna said government ... said Moderna could not defeat case at early stage (Reuters) - Moderna Inc must face a patent infringement lawsuit over its COVID-19 vaccines, a federal judge in ...

(Reuters) -Moderna ... patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech. The company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot ...

Moderna said on Friday (May 17) the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.

London: Moderna has won a case ... COVID shot Comirnaty since it sued them in 2022 for allegedly copying its mRNA technology. Pfizer and BioNTech have also countersued, alleging that Moderna's ...